ZEALLogistics Solution Provider
Zealand Pharma A/S — PE Ratio & Valuation Analysis
₹59.50
+0.00%
Current P/E13.23xPrice to earnings
Industry P/E25.23xSector average
4Y Avg P/E29.0x54.4% below avg
✅
47.6% Discount to Industry
ZEAL P/E 13.23x vs sector avg 25.23x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2023 | ₹7.40 | ₹215 | 29x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Zealand Pharma A/S Valuation
Zealand Pharma A/S (ZEAL) currently trades at 13.23x earnings. The Logistics Solution Provider sector average PE is 25.23x. ZEAL is trading at a discount to peers — may indicate relative value. Historically, ZEAL has traded at an average PE of 29.0x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
19.60%
Dividend Yield
0.00%
More on Zealand Pharma A/S
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.